Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Get ahead of the curve with the top 6 trials to watch ahead of ESC 2026.

European Society of Cardiology 2026 Preview: 6 Trials to Know

In a trial comparing tirzepatide initiation with sitagliptin, the GLP-1/glucose dual agonist displayed greater reductions in major cardiovascular events.

Tirzepatide Demonstrates Cardioprotective Effects in T2D With ASCVD

The phase 3 trial of evolocumab showed cardioprotective effects in patients without prior MI or stroke, regardless of qualifying atherosclerosis or background therapy.

VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes

All cardiovascular disease risks decreased proportionately across all quintiles of diet consistency, according to recent data.

Planetary Health Diet Reduces Risk of Cardiovascular Disease, CHD, Stroke, HF

The Voluntary Sodium Reduction Goals, issued in October 2021, resulted in no significant reduction in sodium content among packaged foods.

FDA-Issued Sodium Targets Ineffective in Reducing Dietary Salt Intake

Catch up on key FDA approvals, major trial updates, and critical clinician insights from the last 6 months.

First Half 2026 Recap - Cardiology

May 2026 saw substantial FDA decisions, major trial results, guideline updates, and more.

10 Cardiology Headlines You Missed in May 2026

Ashkan Shoamanesh, MD, discusses a series of abstracts presented at ESOC 2026 reinforcing asundexian’s protective effect in patients at risk of ischemic stroke or TIA.

Secondary Analyses of OCEANIC-STROKE Confirm Efficacy of Asundexian

FDA granted priority review to asundexian for secondary prevention after non-cardioembolic ischemic stroke or TIA.

FDA Grants Priority Review to Asundexian for Secondary Prevention After Ischemic Stroke

Erin Ferranti, PhD, MPH, discusses the new guidelines and their implications for continued enhancement of both access to and outcomes of postpartum care.

New AHA Recommendations Encourage Improving Postpartum Cardiovascular Care

On the HCPLive stroke page, resources on the topics of medical news and expert insight into CVA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on stroke medicine, and more.